# Stoneridge Inc: overview

SRI · NYSE · CIK 1043337 · [Consumer discretionary](/sectors/consumer-discretionary.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/sri.md) · [Financials](/companies/sri/financials.md) · [Filings](/companies/sri/filings.md) · [Insiders](/companies/sri/insiders.md)

Latest reported revenue: [$181.4m](/filings/0001043337-26-000074.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Aug 5, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, accession 0001043337-26-000074).

## Last eight quarters

| Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [214](/filings/0001043337-25-000125.md) | [218 d](/filings/0001043337-26-000023.md) | [149](/filings/0001043337-26-000052.md) | [158](/filings/0001043337-26-000074.md) | [210](/filings/0001043337-25-000125.md) | [205 d](/filings/0001043337-26-000023.md) | [161](/filings/0001043337-26-000052.md) | [181](/filings/0001043337-26-000074.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | [0.1%](/filings/0001043337-25-000125.md) | [(2.0%) d](/filings/0001043337-26-000023.md) | [(2.9%)](/filings/0001043337-26-000052.md) | [(2.7%)](/filings/0001043337-26-000074.md) | [(1.6%)](/filings/0001043337-25-000125.md) | [(14.4%) d](/filings/0001043337-26-000023.md) | [(5.6%)](/filings/0001043337-26-000052.md) | [(0.7%)](/filings/0001043337-26-000074.md) |
| Net margin | % | [(3.3%)](/filings/0001043337-25-000125.md) | [(2.8%) d](/filings/0001043337-26-000023.md) | [(4.8%)](/filings/0001043337-26-000074.md) | [(5.9%)](/filings/0001043337-26-000074.md) | [(4.5%)](/filings/0001043337-25-000125.md) | [(37.5%) d](/filings/0001043337-26-000023.md) | [(17.4%)](/filings/0001043337-26-000074.md) | [(2.9%)](/filings/0001043337-26-000074.md) |
| Diluted EPS | $ per share | [(0.26)](/filings/0001043337-25-000125.md) | not reported | [(0.26)](/filings/0001043337-26-000052.md) | [(0.34)](/filings/0001043337-26-000074.md) | [(0.34)](/filings/0001043337-25-000125.md) | not reported | [(1.00)](/filings/0001043337-26-000052.md) | [(0.19)](/filings/0001043337-26-000074.md) |
| Free cash flow | $m | [4.6 d](/filings/0001043337-25-000125.md) | [14.0 d](/filings/0001043337-26-000023.md) | [4.8](/filings/0001043337-25-000092.md) | [7.4 d](/filings/0001043337-25-000115.md) | [(2.7) d](/filings/0001043337-25-000125.md) | [2.6 d](/filings/0001043337-26-000023.md) | [(12.3)](/filings/0001043337-26-000052.md) | [7.7 d](/filings/0001043337-26-000074.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets; Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [770](/filings/0001043337-24-000007.md) | [900](/filings/0001043337-25-000012.md) | [976](/filings/0001043337-26-000023.md) | [908](/filings/0001043337-26-000023.md) | [861](/filings/0001043337-26-000023.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | [2.0%](/filings/0001043337-24-000007.md) | [0.3%](/filings/0001043337-25-000012.md) | [1.3%](/filings/0001043337-26-000023.md) | [(0.0%)](/filings/0001043337-26-000023.md) | [(4.5%)](/filings/0001043337-26-000023.md) |
| Net margin | % | [0.4%](/filings/0001043337-24-000007.md) | [(1.6%)](/filings/0001043337-25-000012.md) | [(0.5%)](/filings/0001043337-26-000023.md) | [(1.8%)](/filings/0001043337-26-000023.md) | [(11.9%)](/filings/0001043337-26-000023.md) |
| Diluted EPS | $ per share | [0.12](/filings/0001043337-24-000007.md) | [(0.52)](/filings/0001043337-25-000012.md) | [(0.19)](/filings/0001043337-26-000023.md) | [(0.60)](/filings/0001043337-26-000023.md) | [(3.70)](/filings/0001043337-26-000023.md) |
| Free cash flow | $m | [(59.2)](/filings/0001043337-24-000007.md) | [(20.4)](/filings/0001043337-25-000012.md) | [(33.6)](/filings/0001043337-26-000023.md) | [23.4](/filings/0001043337-26-000023.md) | [12.2](/filings/0001043337-26-000023.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment; Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/sri/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $18.7m | 2,559,252 |  | Added +1,389,647 |
| [22NW, LP](/funds/1694297.md) | 2026-06-30 | $18.1m | 2,466,975 |  | Unchanged |
| [FEDERATED HERMES, INC.](/funds/1056288.md) | 2026-06-30 | $8.9m | 1,214,355 |  | Added +28,755 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $8.8m | 1,203,756 |  | Added +58,775 |
| [Ewing Morris & Co. Investment Partners Ltd.](/funds/1846838.md) | 2026-06-30 | $8.2m | 1,352,980 |  | Reduced −12,074 |
| [DIMENSIONAL FUND ADVISORS LP](/funds/354204.md) | 2026-06-30 | $7.8m | 1,066,041 |  | Reduced −151,933 |
| [AYAL Capital Advisors Ltd](/funds/2011524.md) | 2026-06-30 | $7.4m | 1,004,860 |  | Reduced −84,140 |
| [AMERICAN CENTURY COMPANIES INC](/funds/748054.md) | 2026-06-30 | $7.2m | 980,872 |  | Added +122,407 |
| [ROYCE & ASSOCIATES LP](/funds/906304.md) | 2026-06-30 | $6.1m | 836,293 |  | Added +100,008 |
| [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $5.3m | 721,954 |  | Added +384,530 |

## Recent filings

[All 1,045 filings](/companies/sri/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-07 | 20:32 ET | [8-K](/filings/0001043337-26-000087.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001043337-26-000087 |
| 2026-09-23 | 21:05 ET | [8-K](/filings/0001043337-26-000084.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001043337-26-000084 |
| 2026-08-05 | 21:06 ET | [10-Q](/filings/0001043337-26-000074.md) | Quarterly report, period 2026-06-30 | 0001043337-26-000074 |
| 2026-08-05 | 21:03 ET | [8-K](/filings/0001043337-26-000072.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001043337-26-000072 |
| 2026-06-03 | 21:08 ET | [8-K](/filings/0001043337-26-000061.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001043337-26-000061 |
| 2026-05-26 | 20:39 ET | [8-K](/filings/0001043337-26-000057.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001043337-26-000057 |
| 2026-05-15 | 20:55 ET | [10-Q](/filings/0001043337-26-000052.md) | Quarterly report, period 2026-03-31 | 0001043337-26-000052 |
| 2026-05-07 | 11:34 ET | [8-K](/filings/0001043337-26-000046.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001043337-26-000046 |
| 2026-04-28 | 20:45 ET | [8-K](/filings/0001043337-26-000043.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001043337-26-000043 |
| 2026-04-09 | 20:32 ET | [DEF 14A](/filings/0001043337-26-000038.md) | Proxy statement, period 2026-05-19 | 0001043337-26-000038 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001043337-26-000023.md), filed Mar 16, 2026.

## Forecast league

Q3 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/cf6da73c-7382-4615-872a-4a7ee03ff0a2)

## About the filer

- CIK: 1043337
- Tickers: SRI
- Exchange: NYSE
- SIC code: 3714 Motor Vehicle Parts & Accessories
- State of incorporation: OH
- Filer category: Accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:31 ET. No prices; not investment advice.